<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font18 { font-size : 18; } .font19 { font-size : 19; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font29 { font-size : 29; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; }</style>
 <body>
  <p>
   <span class="font30">and </span>
   <span class="font29">the </span>
   <span class="font19">with </span>
   <span class="font18">were </span>
   <span class="font18">RSV </span>
   <span class="font14">for </span>
   <span class="font14">was </span>
   <span class="font14">Ad.RSV.preF </span>
   <span class="font14">immune </span>
   <span class="font13">immunization </span>
   <span class="font13">mice </span>
   <span class="font13">responses </span>
   <span class="font13">vaccine </span>
   <span class="font13">weeks </span>
   <span class="font13">after </span>
   <span class="font13">neonatal </span>
   <span class="font13">that </span>
   <span class="font12">antibodies </span>
   <span class="font12">virus </span>
   <span class="font12">are </span>
   <span class="font12">respiratory </span>
   <span class="font12">induced </span>
   <span class="font12">response </span>
   <span class="font12">{background </span>
   <span class="font12">syncytial </span>
   <span class="font12">titers </span>
   <span class="font12">The </span>
   <span class="font12">cells </span>
   <span class="font12">(Fig. </span>
   <span class="font11">cellular </span>
   <span class="font11">protein </span>
   <span class="font11">FI-RSV </span>
   <span class="font11">Th-biased </span>
   <span class="font11">adult </span>
   <span class="font11">compared </span>
   <span class="font11">IgG </span>
   <span class="font11">from </span>
   <span class="font11">margin </span>
   <span class="font11">not </span>
   <span class="font11">prefusion </span>
   <span class="font11">Fig. </span>
   <span class="font11">IL-, </span>
   <span class="font11">against </span>
   <span class="font11">when </span>
   <span class="font11">{border-style </span>
   <span class="font11">VNA </span>
   <span class="font11">this </span>
   <span class="font11">both </span>
   <span class="font11">immunized </span>
   <span class="font11">levels </span>
   <span class="font11">px;} </span>
   <span class="font11">using </span>
   <span class="font11">#ffffff;} </span>
   <span class="font11">increased </span>
   <span class="font11">observed </span>
   <span class="font11">between </span>
   <span class="font11">humoral </span>
   <span class="font11">induces </span>
   <span class="font11">Th/Th </span>
   <span class="font11">(Supplementary </span>
   <span class="font11">antibody </span>
   <span class="font11">clinical </span>
   <span class="font11">demonstrated </span>
   <span class="font11">mice, </span>
   <span class="font11">significantly </span>
   <span class="font11">cytokine </span>
   <span class="font11">determined </span>
   <span class="font11">infants </span>
   <span class="font11">per </span>
   <span class="font11">preF </span>
   <span class="font11">splenocytes </span>
   <span class="font11">vector </span>
   <span class="font10">IFN-γ </span>
   <span class="font10">IgGa </span>
   <span class="font10">analysis </span>
   <span class="font10">fusion </span>
   <span class="font10">high </span>
   <span class="font10">infection </span>
   <span class="font10">system </span>
   <span class="font10">ERD </span>
   <span class="font10">IL- </span>
   <span class="font10">dose </span>
   <span class="font10">encoding </span>
   <span class="font10">have </span>
   <span class="font10">immunization. </span>
   <span class="font10">neutralizing </span>
   <span class="font10">received </span>
   <span class="font10">addition, </span>
   <span class="font10">animals </span>
   <span class="font10">group </span>
   <span class="font10">groups </span>
   <span class="font10">its </span>
   <span class="font10">postF </span>
   <span class="font10">prime </span>
   <span class="font10">young </span>
   <span class="font10">Ad.RSV.FA </span>
   <span class="font10">IFN-γ, </span>
   <span class="font10">animal </span>
   <span class="font10">antibodies, </span>
   <span class="font10">cell </span>
   <span class="font10">expressed </span>
   <span class="font10">given </span>
   <span class="font10">immunization, </span>
   <span class="font10">performed </span>
   <span class="font10">post </span>
   <span class="font10">postfusion </span>
   <span class="font10">single </span>
   <span class="font10">whereas </span>
   <span class="font10">F-binding </span>
   <span class="font10">background </span>
   <span class="font10">boost </span>
   <span class="font10">calculated </span>
   <span class="font10">characterized </span>
   <span class="font10">disease </span>
   <span class="font10">higher </span>
   <span class="font10">immunogenicity </span>
   <span class="font10">indicated </span>
   <span class="font10">mice. </span>
   <span class="font10">profile </span>
   <span class="font10">px; </span>
   <span class="font10">ratio </span>
   <span class="font10">results </span>
   <span class="font10">sera </span>
   <span class="font10">similar </span>
   <span class="font10">skewing </span>
   <span class="font10">stimulated </span>
   <span class="font10">{font-family </span>
   <span class="font10">(n =  </span>
   <span class="font10">Ad.RSV.preF-immunized </span>
   <span class="font10">BALB/c </span>
   <span class="font10">ELISA </span>
   <span class="font10">F-specific </span>
   <span class="font10">analyzed </span>
   <span class="font10">been </span>
   <span class="font10">bovine </span>
   <span class="font10">c). </span>
   <span class="font10">challenge </span>
   <span class="font10">children </span>
   <span class="font10">conformation </span>
   <span class="font10">contrast, </span>
   <span class="font10">development </span>
   <span class="font10">durable </span>
   <span class="font10">font-size </span>
   <span class="font10">immunity </span>
   <span class="font10">induce </span>
   <span class="font10">measured </span>
   <span class="font10">numbers </span>
   <span class="font10">previously </span>
   <span class="font10">relatively </span>
   <span class="font10">responses. </span>
   <span class="font10">resulted </span>
   <span class="font10">used </span>
   <span class="font10">vectors </span>
   <span class="font10">which </span>
   <span class="font10">(RSV) </span>
   <span class="font10">(left </span>
   <span class="font10">Ad.RSV.FA, </span>
   <span class="font10">All </span>
   <span class="font10">Day </span>
   <span class="font10">ELISPOT </span>
   <span class="font10">ICS </span>
   <span class="font10">Statistical </span>
   <span class="font10">Supplementary </span>
   <span class="font10">TNF-α </span>
   <span class="font10">age </span>
   <span class="font10">antibodies. </span>
   <span class="font10">available </span>
   <span class="font10">b). </span>
   <span class="font10">candidate </span>
   <span class="font10">detected </span>
   <span class="font10">did </span>
   <span class="font10">double; </span>
   <span class="font10">inactivated </span>
   <span class="font10">induction </span>
   <span class="font10">lower </span>
   <span class="font10">mouse </span>
   <span class="font10">panel) </span>
   <span class="font10">peptide </span>
   <span class="font10">protein, </span>
   <span class="font10">recombinant </span>
   <span class="font10">responses, </span>
   <span class="font10">stabilized </span>
   <span class="font10">studies </span>
   <span class="font10">upon </span>
   <span class="font10">wildtype </span>
   <span class="font10">Bonferroni </span>
   <span class="font10">F-stimulated </span>
   <span class="font10">Immunol. </span>
   <span class="font10">Infect. </span>
   <span class="font10">Long </span>
   <span class="font10">Splenocytes </span>
   <span class="font10">These </span>
   <span class="font10">This </span>
   <span class="font10">Tobit </span>
   <span class="font10">a). </span>
   <span class="font10">adenoviral </span>
   <span class="font10">adenovirus </span>
   <span class="font10">al.A </span>
   <span class="font10">associated </span>
   <span class="font10">based </span>
   <span class="font10">birth </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">cotton </span>
   <span class="font10">data </span>
   <span class="font10">detectable </span>
   <span class="font10">difference </span>
   <span class="font10">expression </span>
   <span class="font10">group. </span>
   <span class="font10">healthy </span>
   <span class="font10">homologous </span>
   <span class="font10">human </span>
   <span class="font10">immunogenic </span>
   <span class="font10">infant </span>
   <span class="font10">intramuscular </span>
   <span class="font10">novel </span>
   <span class="font10">prime-boost </span>
   <span class="font10">regression </span>
   <span class="font10">relative </span>
   <span class="font10">secretion </span>
   <span class="font10">serum </span>
   <span class="font10">shown </span>
   <span class="font10">solid; </span>
   <span class="font10">splenocytes. </span>
   <span class="font10">stained </span>
   <span class="font10">strong </span>
   <span class="font10">study </span>
   <span class="font10">subclass </span>
   <span class="font10">subsequent </span>
   <span class="font10">target </span>
   <span class="font10">test </span>
   <span class="font10">those </span>
   <span class="font10">two </span>
   <span class="font10">very </span>
   <span class="font10">virus-neutralizing </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">(indicated </span>
   <span class="font10">(th </span>
   <span class="font10">Ad.RSV.preF, </span>
   <span class="font10">CDCD </span>
   <span class="font10">Commons </span>
   <span class="font10">Control </span>
   <span class="font10">Creative </span>
   <span class="font10">Dis. </span>
   <span class="font10">Epidemiol. </span>
   <span class="font10">FI-RSV. </span>
   <span class="font10">For </span>
   <span class="font10">Med. </span>
   <span class="font10">Rank </span>
   <span class="font10">Serum </span>
   <span class="font10">Sum </span>
   <span class="font10">Thus, </span>
   <span class="font10">Vaccines </span>
   <span class="font10">Virol. </span>
   <span class="font10">Wilcoxon </span>
   <span class="font10">above </span>
   <span class="font10">added </span>
   <span class="font10">adults </span>
   <span class="font10">all </span>
   <span class="font10">anti-RSV </span>
   <span class="font10">assay </span>
   <span class="font10">assessed </span>
   <span class="font10">birth, </span>
   <span class="font10">bold </span>
   <span class="font10">boosted </span>
   <span class="font10">burden </span>
   <span class="font10">but </span>
   <span class="font10">candidates </span>
   <span class="font10">conformation. </span>
   <span class="font10">control </span>
   <span class="font10">correction. </span>
   <span class="font10">courier; </span>
   <span class="font10">described </span>
   <span class="font10">developed </span>
   <span class="font10">different </span>
   <span class="font10">due </span>
   <span class="font10">effect </span>
   <span class="font10">elicited </span>
   <span class="font10">em; </span>
   <span class="font10">further </span>
   <span class="font10">geometric </span>
   <span class="font10">glycoprotein </span>
   <span class="font10">has </span>
   <span class="font10">helper </span>
   <span class="font10">highly </span>
   <span class="font10">horizontal </span>
   <span class="font10">information </span>
   <span class="font10">isolated </span>
   <span class="font10">later </span>
   <span class="font10">log </span>
   <span class="font10">means </span>
   <span class="font10">might </span>
   <span class="font10">more </span>
   <span class="font10">other </span>
   <span class="font10">our </span>
   <span class="font10">percentages </span>
   <span class="font10">percentile </span>
   <span class="font10">potency </span>
   <span class="font10">potent </span>
   <span class="font10">presence </span>
   <span class="font10">producing </span>
   <span class="font10">pt;} </span>
   <span class="font10">safety </span>
   <span class="font10">samples </span>
   <span class="font10">serotype </span>
   <span class="font10">statistical </span>
   <span class="font10">supernatant </span>
   <span class="font10">these </span>
   <span class="font10">values </span>
   <span class="font10">viral </span>
   <span class="font10">without </span>
  </p>
 </body>
</html>
